Core--Biomolecular analysis

$0P30FY2002CANIH

Burnham Institute For Medical Research, La Jolla CA

Investigators

Linked publications & trials

Paper 39677772 Paper 39627191 Paper 39605455 Paper 39484541 Paper 39386552 Paper 39294158 Paper 39281885 Paper 39229183 Paper 39198884 Paper 39091799 Paper 38949950 Paper 38838144 Paper 38826238 Paper 38805583 Paper 38741205 Paper 38740554 Paper 38729306 Paper 38712107 Paper 38710674 Paper 38464189 Paper 38460130 Paper 38370825 Paper 38260668 Paper 38254907 Paper 38145748 Paper 38136381 Paper 38092754 Paper 38086986 Paper 38048593 Paper 38045344 Paper 37995701 Paper 37986947 Paper 37945900 Paper 37831068 Paper 37814011 Paper 37797233 Paper 37693380 Paper 37601659 Paper 37589340 Paper 37558948 Paper 37550596 Paper 37527776 Paper 37459255 Paper 37416457 Paper 37406115 Paper 37404133 Paper 37390209 Paper 37293707 Paper 37292688 Paper 37279757 Paper 37243192 Paper 37188670 Paper 37150321 Paper 37115668 Paper 37078793 Paper 37039663 Paper 36973293 Paper 36899402 Paper 36893757 Paper 36879684 Paper 36787422 Paper 36638200 Paper 36626549 Paper 36537242 Paper 36532738 Paper 36517396 Paper 36480779 Paper 36473869 Paper 36435939 Paper 36301822 Paper 36264490 Paper 36248604 Paper 36240221 Paper 36219398 Paper 36210051 Paper 36192601 Paper 36097192 Paper 36056555 Paper 36053214 Paper 36050469 Paper 35985330 Paper 35977718 Paper 35880017 Paper 35858375 Paper 35851616 Paper 35840561 Paper 35789254 Paper 35766385 Paper 35748870 Paper 35740568 Paper 35712672 Paper 35680424 Paper 35654839 Paper 35647611 Paper 35574218 Paper 35561126 Paper 35545049 Paper 35469018 Paper 35427646 Paper 35349828

Abstract

Description: (Applicant's Description) The Biomolecular Analysis Facility, a developing shared resource, provides instrumentation and expertise to analyze and characterize the structure and function of biomolecules. This facility will provide the capabilities for measuring ligand-binding kinetics, analyzing protein folding, determining molecular mass, characterizing post-translational modifications and identifying unknown proteins. Techniques include Surface Plasmon Resonance (SPR), Matrix Assisted Laser Desorption/Ionization Mass Spectrometry (MALDI/MS), and Circular dichroism (CD). Future plans include enhancement of existing SPR capability for measuring molecular kinetics and enhancement of MALDI/MS to accommodate small scale proteome analysis. The Biomolecular Analysis Facility is still developing, making it difficult to project precisely the level of use by each lab at the Cancer Center. During the past two years that the Institute has supported SPR and MALDI/MS, the use of each technology increased sufficiently to warrant the purchase of upgraded instrumentation and to organize the facility in a formal manner.

View original record on NIH RePORTER →